skip to Main Content

A Cancer Vaccine Built From Stem Cells? Stanford Candidate Shows Promise in Pancreatic Tumors

Newsfeed image, light gray text on dark gray background
Cancer vaccines that prime the immune system to recognize and eliminate cancer cells have gained traction lately. Scientists are pursuing a wide range of strategies including making vaccines from immune cells, tumor cells, tumor-associated proteins or their smaller components.

Now, a team at Stanford University has demonstrated that a cancer vaccine made from induced pluripotent stem cells (iPSCs), together with an immune adjuvant, could protect against pancreatic cancer in mouse models. The findings were published in the journal Stem Cell Reports. Read more . . .

Back To Top